Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06199193
NA

Design of Personalised SupplemenTs Based on the Gut MicRobiota Through Artificial Intelligence for Alzheimer's Patients

Sponsor: Universidad Complutense de Madrid

View on ClinicalTrials.gov

Summary

Studies indicate that the intestinal microbiota could have an implication in Alzheimer's disease; recently, a positive relationship has been established between levels of bacterial lipopolysaccharide (LPS) and cerebral amyloidosis and a negative relationship between the production of the chain fatty acid cuts butyrate by the intestinal microbiota and cerebral amyloidosis. Currently there is no effective treatment for Alzheimer's, but studies indicate that a healthy diet such as the Mediterranean diet and physical exercise delay the symptoms of this disease. For all these reasons, it is postulated that introducing changes in the intestinal microbiota through diet may be a new treatment or serve as an adjuvant treatment for Alzheimer's disease.

Official title: Design of Personalised SupplemenTs Based on the Gut MicRobiota of Alzheimer Patients Through Network and Artificial Intelligence Analysis

Key Details

Gender

All

Age Range

60 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2024-02-01

Completion Date

2025-12-31

Last Updated

2024-12-09

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

Personalized diet

Personalized supplement designed by artificial intelligence based on the intestinal microbiota and incorporated into diets

DIETARY_SUPPLEMENT

Dietary counseling

Dietary advice will be provided to adapt the diet to the nutritional objectives and recommended intakes.

Locations (2)

Hospital Universitario Puerta de Hierro

Majadahonda, Madrid, Spain

Hospital Clínico Universitario Virgen de la Arrixaca

Murcia, Murcia, Spain